Jayaprakash Madhavan

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study

Tudor–Eliade Ciuleanu, Thomas Brodowicz, Christoph Zielinski et al. · The Lancet · 2009 · 1.1K citations · Full text

Non-small-cell Lung Cancer, Medicine, Cancer Management +6

Diagnostic Value of 68Ga PSMA-11 PET/CT Imaging of Brain Tumors—Preliminary Analysis

Arun Sasikumar, Ajith Joy, M. R. A. Pillai et al. · Clinical Nuclear Medicine · 2016 · 130 citations

Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population

Leelakumari Sreeja, Vani Syamala, Sreedharan Hariharan et al. · Journal of Human Genetics · 2005 · 93 citations · Full text

South Indian Population, Oncology, Possible Risk Modification +11

Oral cancer detection using diffuse reflectance spectral ratio R540∕R575 of oxygenated hemoglobin bands

Narayanan Subhash, J. R. Mallia, Shiny Sara Thomas et al. · Journal of Biomedical Optics · 2006 · 88 citations · Full text

Oral Cancer Detection, Pathology, Diffuse Reflectance Intensity +19

Randomized, Double-Blind, Placebo-Controlled Phase II Study of Single-Agent Oral Talactoferrin in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer That Progressed After Chemotherapy

Purvish M. Parikh, Ashok K. Vaid, Suresh H. Advani et al. · Journal of Clinical Oncology · 2011 · 75 citations · Full text